The Heart Rhythm Society’s 36th Annual Scientific Sessions, May 13-16, 2015 in Boston, will offer the latest clinical data and new technology updates in electrophysiology (EP). These include new information on leadless pacing, the impact of wireless remote device monitoring, the latest advances in atrial fibrillation management and shockless ICD implant evaluations. 

May 11, 2015 — The Heart Rhythm Society (HRS) has released the list of its 12 late-breaking electrophysiology (EP) clinical trials that will be presented at Heart Rhythm 2015, which takes place May 13-16, 2015 in Boston. 

Medtronic plc announced it has received CE (Conformité Européenne) Mark for the Micra Transcatheter Pacing System (TPS), the world’s smallest pacemaker. At less than one-tenth the size of traditional pacemakers, the Micra device provides advanced pacing technology while being cosmetically invisible and small enough to be delivered with minimally invasive techniques through a catheter, and implanted directly into the heart.

Boston Scientific Corp. presented an overview of its continued business momentum and long-term growth strategies at a meeting with the investment community May 1.

The ScottCare Corp. announced it will highlight Ambucor, the company’s employable labor service division for CIED monitoring, at the 2015 Heart Rhythm Society Scientific Sessions in Boston, May 13-16.

ECRI Institute, point-of-care ultrasound, POC, guide

As the use of point-of-care (POC) ultrasound continues to expand throughout hospitals and clinics, the ECRI Institute has released a new guide to the modality for practitioners. The document explains the difference between POC and traditional ultrasound, the different types of POC ultrasound units and the numerous applications for the technology.
heart regeneration, zebrafish, epicardium, Duke, Poss

While the human heart can’t heal itself, the zebrafish heart can easily replace cells lost by damage or disease. Now, researchers have discovered properties of a mysterious outer layer of the heart known as the epicardium that could help explain the fish’s remarkable ability to regrow cardiac tissue.

Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the Euphora Semicompliant Balloon Dilatation Catheter. Euphora is a pre-dilatation therapy used during a stent implantation to reopen a narrowed coronary artery caused by plaque buildup.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now